Work

Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma

Year: 2023
Type: erratum
Abstract: In the version of this article initially published, the surname of author Michael T. Tetzlaff was misspelled as ‘Tezlaff.’ In addition, the Acknowledgements section omitted mention of grant P50CA221703 from the National Cancer Institute of the National Institutes of Health, which supported the work. The errors have been corrected in the HTML and PDF versions of the article.
Source: Nature
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $11,690
OpenAlex ID: W4323669295
Cites:
Cited by: 2
Related to: 10